These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 10051540)
21. Oncogenic transformation potentiates apoptosis, S-phase arrest and stress-kinase activation by etoposide. Chen G; Shu J; Stacey DW Oncogene; 1997 Oct; 15(14):1643-51. PubMed ID: 9349497 [TBL] [Abstract][Full Text] [Related]
22. Dexamethasone induces apoptosis of multiple myeloma cells in a JNK/SAP kinase independent mechanism. Chauhan D; Pandey P; Ogata A; Teoh G; Treon S; Urashima M; Kharbanda S; Anderson KC Oncogene; 1997 Aug; 15(7):837-43. PubMed ID: 9266970 [TBL] [Abstract][Full Text] [Related]
23. Antitumor activity of lysophosphatidic acid acyltransferase-beta inhibitors, a novel class of agents, in multiple myeloma. Hideshima T; Chauhan D; Hayashi T; Podar K; Akiyama M; Mitsiades C; MItsiades N; Gong B; Bonham L; de Vries P; Munshi N; Richardson PG; Singer JW; Anderson KC Cancer Res; 2003 Dec; 63(23):8428-36. PubMed ID: 14679006 [TBL] [Abstract][Full Text] [Related]
24. Catalytic inhibitors of topoisomerase II are DNA-damaging agents: induction of chromosomal damage by merbarone and ICRF-187. Wang L; Eastmond DA Environ Mol Mutagen; 2002; 39(4):348-56. PubMed ID: 12112387 [TBL] [Abstract][Full Text] [Related]
25. Methylseleninic acid potentiates apoptosis induced by chemotherapeutic drugs in androgen-independent prostate cancer cells. Hu H; Jiang C; Ip C; Rustum YM; Lü J Clin Cancer Res; 2005 Mar; 11(6):2379-88. PubMed ID: 15788689 [TBL] [Abstract][Full Text] [Related]
26. Differences in inhibition of chromosome separation and G2 arrest by DNA topoisomerase II inhibitors merbarone and VM-26. Chen M; Beck WT Cancer Res; 1995 Apr; 55(7):1509-16. PubMed ID: 7882360 [TBL] [Abstract][Full Text] [Related]
27. In vitro and intracellular inhibition of topoisomerase II by the antitumor agent merbarone. Drake FH; Hofmann GA; Mong SM; Bartus JO; Hertzberg RP; Johnson RK; Mattern MR; Mirabelli CK Cancer Res; 1989 May; 49(10):2578-83. PubMed ID: 2540903 [TBL] [Abstract][Full Text] [Related]
28. c-Jun NH2-terminal kinase-mediated activation of interleukin-1beta converting enzyme/CED-3-like protease during anticancer drug-induced apoptosis. Seimiya H; Mashima T; Toho M; Tsuruo T J Biol Chem; 1997 Feb; 272(7):4631-6. PubMed ID: 9020192 [TBL] [Abstract][Full Text] [Related]
29. Fas activation of the p38 mitogen-activated protein kinase signalling pathway requires ICE/CED-3 family proteases. Juo P; Kuo CJ; Reynolds SE; Konz RF; Raingeaud J; Davis RJ; Biemann HP; Blenis J Mol Cell Biol; 1997 Jan; 17(1):24-35. PubMed ID: 8972182 [TBL] [Abstract][Full Text] [Related]
30. Differential cell cycle-specificity for chromosomal damage induced by merbarone and etoposide in V79 cells. Wang L; Roy SK; Eastmond DA Mutat Res; 2007 Mar; 616(1-2):70-82. PubMed ID: 17174356 [TBL] [Abstract][Full Text] [Related]
31. Activation of p38 mitogen-activated protein kinase and caspases in UVB-induced apoptosis of human keratinocyte HaCaT cells. Shimizu H; Banno Y; Sumi N; Naganawa T; Kitajima Y; Nozawa Y J Invest Dermatol; 1999 May; 112(5):769-74. PubMed ID: 10233770 [TBL] [Abstract][Full Text] [Related]
32. 7-Hydroxystaurosporine (UCN-01) induces apoptosis in human colon carcinoma and leukemia cells independently of p53. Shao RG; Shimizu T; Pommier Y Exp Cell Res; 1997 Aug; 234(2):388-97. PubMed ID: 9260909 [TBL] [Abstract][Full Text] [Related]
33. Topoisomerase II inhibitors affect entry into mitosis and chromosome condensation in BHK cells. Anderson H; Roberge M Cell Growth Differ; 1996 Jan; 7(1):83-90. PubMed ID: 8788036 [TBL] [Abstract][Full Text] [Related]
34. Down-regulation of topoisomerase IIalpha in CEM cells selected for merbarone resistance is associated with reduced expression of Sp3. Mo YY; Wang Q; Beck WT Cancer Res; 1997 Nov; 57(22):5004-8. PubMed ID: 9371492 [TBL] [Abstract][Full Text] [Related]
35. Fas induces cytoplasmic apoptotic responses and activation of the MKK7-JNK/SAPK and MKK6-p38 pathways independent of CPP32-like proteases. Toyoshima F; Moriguchi T; Nishida E J Cell Biol; 1997 Nov; 139(4):1005-15. PubMed ID: 9362518 [TBL] [Abstract][Full Text] [Related]
36. Induction of apoptosis by deregulated expression of DNA topoisomerase IIalpha. McPherson JP; Goldenberg GJ Cancer Res; 1998 Oct; 58(20):4519-24. PubMed ID: 9788593 [TBL] [Abstract][Full Text] [Related]
37. G2 arrest in response to topoisomerase II inhibitors: the role of p53. Clifford B; Beljin M; Stark GR; Taylor WR Cancer Res; 2003 Jul; 63(14):4074-81. PubMed ID: 12874009 [TBL] [Abstract][Full Text] [Related]
38. The DNA topoisomerase II catalytic inhibitor merbarone is genotoxic and induces endoreduplication. Pastor N; Domínguez I; Orta ML; Campanella C; Mateos S; Cortés F Mutat Res; 2012; 738-739():45-51. PubMed ID: 22921906 [TBL] [Abstract][Full Text] [Related]
39. Selective induction of apoptosis in Hep 3B cells by topoisomerase I inhibitors: evidence for a protease-dependent pathway that does not activate cysteine protease P32. Adjei PN; Kaufmann SH; Leung WY; Mao F; Gores GJ J Clin Invest; 1996 Dec; 98(11):2588-96. PubMed ID: 8958222 [TBL] [Abstract][Full Text] [Related]
40. The activation of the c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signaling pathways protects HeLa cells from apoptosis following photodynamic therapy with hypericin. Assefa Z; Vantieghem A; Declercq W; Vandenabeele P; Vandenheede JR; Merlevede W; de Witte P; Agostinis P J Biol Chem; 1999 Mar; 274(13):8788-96. PubMed ID: 10085120 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]